{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T09:19:45Z","timestamp":1768641585991,"version":"3.49.0"},"reference-count":93,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T00:00:00Z","timestamp":1555632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Pfizer Inc","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2019,9,2]]},"DOI":"10.1080\/21645515.2019.1581542","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T20:52:10Z","timestamp":1550609530000},"page":"2205-2216","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["Concomitant administration of meningococcal vaccines with other vaccines in adolescents and adults: a review of available evidence"],"prefix":"10.1080","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3006-1675","authenticated-orcid":false,"given":"Justine","family":"Alderfer","sequence":"first","affiliation":[{"name":"Pfizer Vaccines Medical Development & Scientific and Clinical Affairs , Collegeville, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2510-5058","authenticated-orcid":false,"given":"Amit","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines Medical Development & Scientific and Clinical Affairs , Collegeville, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raul","family":"Isturiz","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines Medical Development & Scientific and Clinical Affairs , Collegeville, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Burman","sequence":"additional","affiliation":[{"name":"Pfizer Vaccines Medical Development & Scientific and Clinical Affairs , Collegeville, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Absalon","sequence":"additional","affiliation":[{"name":"Pfizer Vaccine Clinical Research and Development , Pearl River, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Beeslaar","sequence":"additional","affiliation":[{"name":"Pfizer UK Clinical Vaccine Research and Development , Hurley, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Perez","sequence":"additional","affiliation":[{"name":"Pfizer Vaccine Clinical Research and Development , Collegeville, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2019,4,19]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000282"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.4161\/hv.22302"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)67932-4"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.12.062"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.04.063"},{"key":"cit0006","unstructured":"Centers for Disease Control and Prevention . Enhanced meningococcal disease surveillance report, 2016. [accessed 2018 Apr 2]. https:\/\/www.cdc.gov\/meningococcal\/downloads\/NCIRD-EMS-Report.pdf."},{"key":"cit0007","unstructured":"European Centre for Disease Prevention and Control . Invasive meningococcal disease. [accessed 2017 Nov 11]. https:\/\/ecdc.europa.eu\/sites\/portal\/files\/documents\/Invasive%20meningococcal%20disease%20AER.pdf."},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2013.05.009"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6633a2"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2017.3140"},{"issue":"2","key":"cit0011","first-page":"1","volume":"60","author":"National Center for Immunization and Respiratory Diseases","year":"2011","journal-title":"MMWR Recomm Rep"},{"issue":"29","key":"cit0012","first-page":"620","volume":"63","author":"Stokley S","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"cit0013","unstructured":"European Centre for Disease Prevention and Control . Recommended immunisations for diphtheria. [accessed 2017 Nov 9]. http:\/\/vaccine-schedule.ecdc.europa.eu\/Pages\/Scheduler.aspx."},{"key":"cit0014","unstructured":"European Centre for Disease Prevention and Control . Recommended immunisations for human papillomavirus infection. [accessed 2017 November 9]. http:\/\/vaccine-schedule.ecdc.europa.eu\/Pages\/Scheduler.aspx."},{"key":"cit0015","unstructured":"European Centre for Disease Prevention and Control . Recommended immunisations for tetanus. [accessed 2017 November 9]. http:\/\/vaccine-schedule.ecdc.europa.eu\/Pages\/Scheduler.aspx."},{"key":"cit0016","unstructured":"European Centre for Disease Prevention and Control . Recommended immunisations for pertussis. [accessed 2017 November 9]. http:\/\/vaccine-schedule.ecdc.europa.eu\/Pages\/Scheduler.aspx."},{"key":"cit0017","unstructured":"European Centre for Disease Prevention and Control . Recommended immunisations for influenza. [accessed 2017 November 9]. http:\/\/vaccine-schedule.ecdc.europa.eu\/Pages\/Scheduler.aspx."},{"key":"cit0018","unstructured":"European Centre for Disease Prevention and Control . Recommended immunisations for meningococcal disease. [accessed 2017 July 20]. http:\/\/vaccine-schedule.ecdc.europa.eu\/Pages\/Scheduler.aspx."},{"key":"cit0019","unstructured":"Centers for Disease Control and Prevention . Recommended immunization schedules for persons aged 0 through 18 years, United States, 2017. [accessed 2017 July 18]. https:\/\/www.cdc.gov\/vaccines\/schedules\/downloads\/child\/0-18yrs-child-combined-schedule.pdf."},{"key":"cit0020","unstructured":"Centers for Disease Control and Prevention . Recommended immunization schedule for adults aged 19 years or older, United States, 2017. [accessed 2017 June 21]. https:\/\/www.cdc.gov\/vaccines\/schedules\/downloads\/adult\/adult-combined-schedule.pdf."},{"key":"cit0021","unstructured":"European Centre for Disease Prevention and Control . Recommended immunisations for hepatitis B. [accessed 2019 March 6]. http:\/\/vaccine-schedule.ecdc.europa.eu\/Pages\/Scheduler.aspx."},{"key":"cit0022","unstructured":"European Centre for Disease Prevention and Control . Recommended immunisations for varicella. [accessed 2019 March 6]. http:\/\/vaccine-schedule.ecdc.europa.eu\/Pages\/Scheduler.aspx."},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.06.026"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000247070.60063.09"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.10.013"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2005.076109"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.07.060"},{"key":"cit0028","volume-title":"Full Prescribing Information","author":"Menactra\u00ae (MCV4)","year":"2014"},{"key":"cit0029","volume-title":"Full Prescribing Information","author":"Menveo\u00ae (Meningococcal [Groups A, C, Y and W-135] Oligosaccharide Diphtheria CRM197 Conjugate Vaccine)","year":"2013"},{"key":"cit0030","volume-title":"Nimenrix Product Monograph","author":"Pfizer Canada Inc","year":"2016"},{"key":"cit0031","volume-title":"Full Prescribing Information","author":"MenAfriVac (meningococcal A conjugate vaccine)","year":"2015"},{"key":"cit0032","volume-title":"Summary of Product Characteristics","author":"Menjugate 10 micrograms suspension for injection (meningococcal group C conjugate vaccine)","year":"2016"},{"key":"cit0033","volume-title":"Full Prescribing Information","author":"Meningitec (meningococcal serogroup c conjugate vaccine)","year":"2011"},{"key":"cit0034","volume-title":"Full Prescribing Information","author":"NeisVac-C (meningococcal C conjugate vaccine)","year":"2015"},{"key":"cit0035","volume-title":"Full Prescribing Information","author":"MENHIBRIX\u00ae (Hib-MenCY-TT)","year":"2013"},{"key":"cit0036","volume-title":"Summary of Product Characteristics","author":"Menitorix (Haemophilus type b and meningococcal group C conjugate vaccine)","year":"2015"},{"key":"cit0037","unstructured":"Ministerio de Salud (Gobierno de Chile) . Vaccination Calendar 2017. [accessed 2017 August 29]. http:\/\/vacunas.minsal.cl\/calendario-de-vacunacion-2017\/."},{"key":"cit0038","unstructured":"State of Kuwait . Schedule of essential vaccination by age, State of Kuwait, 2008. [accessed 2017 August 29]. https:\/\/www.e.gov.kw\/sites\/kgoEnglish\/Pages\/CitizensResidents\/Health\/BasicVaccinationsInKuwait.aspx."},{"key":"cit0039","unstructured":"Kingdom of Saudia Arabia Ministry of Health . Vaccination certificate. [accessed 2017 August 29]. http:\/\/www.moh.gov.sa\/HealthAwareness\/EducationalContent\/HealthInstructions\/Documents\/\u062c\u062f\u0648\u0644%20\u0627\u0644\u062a\u0637\u0639\u064a\u0645\u0627\u062a.pdf."},{"issue":"2","key":"cit0040","first-page":"1","volume":"62","author":"Cohn AC","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.07.083"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-2193"},{"key":"cit0043","volume-title":"Meningococcal group B vaccine","author":"Trumenba\u00ae","year":"2016"},{"key":"cit0044","volume-title":"Full Prescribing Information","author":"Bexsero\u00ae (Meningococcal group B vaccine)","year":"2015"},{"key":"cit0045","unstructured":"National Advisory Committee on Immunization . Advice for the use of the multicomponent meningococcal serogroup B (4CMenB) vaccine. [accessed 2017 August 29]. http:\/\/publications.gc.ca\/collections\/collection_2014\/aspc-phac\/HP40-104-2014-eng.pdf."},{"issue":"22","key":"cit0046","first-page":"608","volume":"64","author":"Folaranmi T","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6441a3"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6619a6"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.9.4946-4954.2002"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.4161\/hv.2.6.3388"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-2084"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1128\/cvi.00267-16"},{"key":"cit0053","unstructured":"World Health Organization . WHO Expert Committee on biological standardization: Twenty-seventh report. [accessed 2018 August 3]. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/37954\/WHO_TRS_594.pdf?sequence=1&isAllowed=y."},{"key":"cit0054","first-page":"589","volume":"2","author":"Keiser P","year":"2012","journal-title":"Future Sci"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.01.051"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.10.5.780-786.2003"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1084\/jem.129.6.1307"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.12.8.970-976.2005"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.07.019"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.04.065"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.03.091"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.02.045"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1128\/cvi.00436-09"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001124"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001072"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piv064"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31822d28df"},{"key":"cit0068","unstructured":"Product Monograph: Menactra\u00ae . [accessed 2018 June 5]. https:\/\/www.vaccineshoppecanada.com\/document.cfm?file=menactra_e.pdf."},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7560.1000231"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.11.051"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2009-2336"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-4199"},{"key":"cit0073","unstructured":"Clinical review of Biologics License Application for human papillomavirus 6, 11, 16, 18 L1 virus like particle vaccine (S. cerevisiae) (STN 125126 GARDASIL), manufactured by Merck, Inc. [accessed 2018 May 9]. http:\/\/wayback.archive-it.org\/7993\/20170723091811\/https:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM111287.pdf."},{"key":"cit0074","unstructured":"US Food and Drug Administration . Clinical review of biologics license application supplement STN# 125126\/1297.0 \u2013 male indication for GARDASIL. [accessed 2017 October 31]. http:\/\/wayback.archive-it.org\/7993\/20170722072813\/https:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM190977.pdf."},{"key":"cit0075","volume-title":"Full prescribing information","author":"Gardasil (human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant)","year":"2014"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1111\/jtm.12164"},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2014.04.011"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1111\/jtm.12180"},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/154.5.893"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.10.020"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.4161\/hv.20212"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.05.027"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.85"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61961-8"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2017.01.011"},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6643a3"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1016\/j.acap.2018.01.002"},{"issue":"13","key":"cit0088","first-page":"1","volume":"45","author":"Immunization of adolescents","year":"1996","journal-title":"MMWR Recomm Rep"},{"key":"cit0089","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6605e1"},{"issue":"7","key":"cit0090","first-page":"1","volume":"54","author":"Bilukha OO","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"cit0091","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1614474"},{"key":"cit0092","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31921-3"},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.03.001"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tandfonline.com\/doi\/pdf\/10.1080\/21645515.2019.1581542","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2019.1581542","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T01:19:30Z","timestamp":1599355170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2019.1581542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,19]]},"references-count":93,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9,2]]}},"alternative-id":["10.1080\/21645515.2019.1581542"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2019.1581542","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-11-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}